Neste vídeo apresentamos um caso clínico fictício, de Ana, 28 anos, secretária, sem doenças conhecidas e sem medicação habitual que tem inicio súbito de cólica abdominal, diarreia sem sangue, febre de 37,8ºC e um vómito.
Neste vídeo apresentamos um caso clínico fictício, de Pedro, 11 anos, saudável, que 8 horas após a ingestão de gelado tem naúseas, cólica abdominal e 7 dejeções líquidas sem sangue.
Neste vídeo apresentamos um caso clínico fictício, de António, 68 anos, diabético hipertenso com queixas desde há vários anos de duas dejeções por semana, de fezes rijas, com necessidade de grande esforço para defecar.
Neste vídeo apresentamos um caso clínico fictício, de Luísa, 12 anos, que faz uma dieta com baixo teor de liquidos e fibras e tem um trânsito intestinal lento que lhe provoca fezes secas e duras. Atualmente, devido a ter uma fissura anal, quando evacua tem dor e ardor anal e o medo de evacuar agrava a sua obstipação.
To compare salivary pH changes and stimulation efficacy of two different gustatory stimulants of salivary secretion (GSSS) in patients with primary Sjögren syndrome.
Um ensaio clínico, publicado na revista científica Journal of Dental Research, demonstra que enxaguar a boca durante um minuto com colutórios com CPC reduz a quantidade de vírus infeciosos na saliva, tais como o SARS-CoV-2.
Chlorhexidine (CHX) mouth rinse/spray can still be considered the gold standard in the chemical prevention of plaque formation and development of gingivitis.
To assess the clinical and microbiological efficacy of a 0.05% chlorhexidine and 0.05% cetyl-pyridinium chloride mouth rinse in supportive periodontal care (SPC) in patients with inadequate plaque control.
To evaluate the clinical and microbiological activity of a new mouth rinse formulation, used as an adjunct to oral hygiene, for patients in supportive periodontal care.
Um ensaio clínico, publicado na revista científica Journal of Dental Research, demonstra que enxaguar a boca por um minuto com colutórios com Cloreto de Cetilpiridínio (CPC) reduz a quantidade de vírus infeciosos na saliva, como o SARS-CoV-2.
Gut microbiome manipulation to alter the gut-lung axis may potentially protect humans against respiratory infections, and clinical trials of probiotics show promise in this regard in healthy adults and children.
This 9-month randomised, parallel, double-blind, single-centre, placebo-controlled study (PROBE, ISRCTN18030882) assessed the impact of probiotic supplementation on bodyweight.
In a double-blind, randomised, parallel-group, placebo-controlled study, healthy school children aged 3-10 years received a probiotic based supplement daily for 6 months to assess the impact on the incidence and duration of upper respiratory tract infection (URTI) symptoms.
In an exploratory, block-randomised, parallel, double-blind, single-centre, placebo-controlled superiority study (ISRCTN12562026, funded by Cultech Ltd), 220 Bulgarian participants (30 to 65 years old) with BMI 25–34.9kg/m2 received Lab4P probiotic (50 billion/day) or a matched placebo for 6 months.
We hypothesized that probiotic supplementation (PRO) increases the absorption and oxidation of orally ingested maltodextrin during 2 h endurance cycling, thereby sparing muscle glycogen for a subsequent time trial (simulating a road race).
To evaluate the effects of probiotic supplementation on gastrointestinal (GI) symptoms, circulatory markers of GI permeability, damage, and markers of immune response during a marathon race.
Gastrointestinal (GI) ischemia during exercise is associated with luminal permeability and increased systemic lipopolysaccharides (LPS). This study aimed to assess the impact of a multistrain pro/prebiotic/antioxidant intervention on endotoxin unit levels and GI permeability in recreational athletes.
Objective: To evaluate a multistrain, high-dose probiotic in the prevention of eczema. Design: A randomised, double-blind, placebo-controlled, parallel group trial. Settings: Antenatal clinics, research clinic, children at home.
Consumidor final
800 910 112
Linha telefónica gratuita
Telefone geral
214 758 300
Chamada para a rede fixa nacional
Login